Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ginsberg

Showing results (61-70 of 369) with videos related to

Pageof 37
Sort By:
Gastroenterology|April 19, 2006
Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver diseaseIra J Goldberg, Henry N Ginsberg
Journal of Lipid Research|December 4, 2008
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolismHenry N Ginsberg, Edward A Fisher
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemiaHenry N Ginsberg, Paul R Maccallum
Trends in Endocrinology and Metabolism: TEM|May 28, 2011
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistanceSung Hee Choi, Henry N Ginsberg
Diabetes Care|April 24, 2014
Gerald M. Reaven, MD: Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular diseaseFredric B Kraemer, Henry N Ginsberg
Pediatric Nephrology (Berlin, Germany)|March 29, 2007
Lipoprotein metabolism in chronic renal insufficiencyJeffrey M Saland, Henry N Ginsberg
Endocrinology and Metabolism Clinics of North America|September 9, 2006
Diabetic dyslipidemiaTina J Chahil, Henry N Ginsberg
Journal of the American College of Cardiology|October 26, 2019
Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 YearsM John Chapman, Henry N Ginsberg
Clinical Nuclear Medicine|October 1, 1987
Three-phase bone scanning in chronic myelogenous leukemiaH N Ginsberg, L C Swayne
Journal of Lipid Research|June 27, 2019
Life is complicated: so is apoCIIIGissette Reyes-Soffer, Henry N Ginsberg
Pageof 37

Showing results (61-70 of 369) with videos related to

Sort By:
Pageof 37
Gastroenterology|April 19, 2006
Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver diseaseIra J Goldberg, Henry N Ginsberg
Journal of Lipid Research|December 4, 2008
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolismHenry N Ginsberg, Edward A Fisher
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2009
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemiaHenry N Ginsberg, Paul R Maccallum
Trends in Endocrinology and Metabolism: TEM|May 28, 2011
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistanceSung Hee Choi, Henry N Ginsberg
Diabetes Care|April 24, 2014
Gerald M. Reaven, MD: Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular diseaseFredric B Kraemer, Henry N Ginsberg
Pediatric Nephrology (Berlin, Germany)|March 29, 2007
Lipoprotein metabolism in chronic renal insufficiencyJeffrey M Saland, Henry N Ginsberg
Endocrinology and Metabolism Clinics of North America|September 9, 2006
Diabetic dyslipidemiaTina J Chahil, Henry N Ginsberg
Journal of the American College of Cardiology|October 26, 2019
Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 YearsM John Chapman, Henry N Ginsberg
Clinical Nuclear Medicine|October 1, 1987
Three-phase bone scanning in chronic myelogenous leukemiaH N Ginsberg, L C Swayne
Journal of Lipid Research|June 27, 2019
Life is complicated: so is apoCIIIGissette Reyes-Soffer, Henry N Ginsberg
Pageof 37